Transpacific TAVR Registry

Last updated: August 4, 2024
Sponsor: Duk-Woo Park, MD
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

TAVR

Clinical Study ID

NCT03826264
AMCCV2019-01
  • Ages > 19
  • All Genders

Study Summary

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All patients undergoing TAVR

  • Informed consent

Study Design

Total Participants: 10000
Treatment Group(s): 1
Primary Treatment: TAVR
Phase:
Study Start date:
June 15, 2019
Estimated Completion Date:
December 31, 2036

Study Description

This study is connected with Asian TAVR registry(NCT02308150). Some subjects from Asian TAVR registry continue 10 years follow-up on this TP-TAVR registry.

Connect with a study center

  • Second Affiliated Hospital of Zhejiang University

    Hangzhou,
    China

    Active - Recruiting

  • Bucheon Sejong Hospital

    Bucheon,
    Korea, Republic of

    Site Not Available

  • Chungnam National University Hospital

    Daejeon,
    Korea, Republic of

    Active - Recruiting

  • Asan Medical Center

    Seoul,
    Korea, Republic of

    Active - Recruiting

  • Seoul National University Hospital

    Seoul,
    Korea, Republic of

    Completed

  • Cheng Hsin General Hospital

    Taipei,
    Taiwan

    Site Not Available

  • Stanford University

    Stanford, California 94305
    United States

    Active - Recruiting

  • Northwestern Memorial Hospital

    Chicago, Illinois 60611
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.